You searched for "oncology"
Robotic Urology Fellowship at UCLH
1 May 2016
| Imran Ahmad
|
URO - Core Urology
In November 2014, approaching my final year of training (ST7) in the West of Scotland (WoS) and just recently armed with my FRCS (Urol), I was at a crossroad in my clinical career. I was keen to pursue a consultant...
Sarcomatoid renal cell carcinoma
1 September 2017
| Paul Cleaveland, Vincent Tang
|
URO - Urologic Oncology
Renal cell carcinoma (RCC) represents 2-3% of all cancers [1]. It is an adenocarcinoma making up 85% of all renal malignancies. Sarcomatoid transformation is a microscopically identified feature of RCC accounting for 5% of all RCCs [2]. Known as sarcomatoid...
In conversation with Sarika Nalagatla
29 June 2023
| Sarika Nalagatla
|
URO - Core Urology
We were delighted to catch up with Sarika Nalagatla, new Chair of the BAUS Section of Trainees (BSoT) about her life as a trainee urologist and plans for the association. Can you tell us a little bit about what led...
SURG and BAUS: United Strength is Stronger
1 September 2018
| Luke Forster, Katie E Chan, Jonathan Noël, Dora Moon, Louise E Olson
|
URO - Core Urology
Tuesday 26 June 2018, SURG Session, BAUS Annual Conference, Liverpool After a busy day of posters, keynote speakers, e-poster sessions and a resounding victory for the SURG team over the consultants in Urology University Challenge, came the SURG meeting. An...
The Parnell Fund Bursary 2019
1 July 2019
| Rachel Barratt
|
URO - Functional / Reconstructive Urology
At the start of July 2019 applications for the Parnell Fund Bursary were opened to trainees, consultants and healthcare professionals across the United Kingdom with an interest in female, functional and neuro-urology. Rachel Barratt, who was awarded the Parnell Fund...
The impact of menopause on bladder symptoms
The menopause is a natural process of ageing when the ovaries completely stop producing reproductive hormones (oestrogen and other sex steroids), and there are no monthly periods for 12 consecutive months. It normally occurs between the ages of 45-55 years...Focal therapy for prostate cancer – ready for prime time?
1 November 2016
| Taimur Shah, Manit Arya, Hashim U Ahmed (Prof)
|
URO - Basic Science Research, URO - Urologic Oncology
The current therapeutic ratio for radical therapy in many men with localised prostate cancer is not ideal. For a significant side-effect profile, there seems to be a small survival benefit over a 10-15 year period. A strategy that might balance...
BAUS Annual Scientific Meeting 2024
9 July 2024
| Toni Huw Mihailidis, Mriganka Mani Sinha
|
URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatric Urology, URO - Core Urology, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Day 1 Toni Huw Mihailidis and Mriganka Mani Sinha Another year and another brilliant meeting in which urologists from the UK and around the globe assembled for a highly entertaining event. Day one kicked off with a topical and ever-pervasive...
Management of RHC in prostate cancer with selective embolisation and hyperbaric oxygen therapy
4 July 2024
| Asif H Ansari, Dev Gulur
|
URO - Urologic Oncology
Prostate cancer is one of the most prevalent malignancies affecting men worldwide. Radiotherapy is a common treatment modality for localised and locally advanced prostate cancer. While radiotherapy can be effective, it may lead to complications such as radiation-induced haemorrhagic cystitis...
In conversation with Professor Christopher Chapple
1 March 2017
|
URO - Core Urology
Professor Christopher Chappel. Prof Chapple, thank you for taking the time to chat with the Urology News team. Can we start by asking about your background and how you ended up in the field of urology? Early in my career...
Testicular cancer: management of stage I seminoma
1 July 2014
| Eleni Josephides, Simon Chowdhury
|
URO - Urologic Oncology
Introduction Testicular cancer is the most frequently occurring solid tumour in men between the ages of 15 and 34 years [1]. About 60% of cases are seminomas and approximately 70-80% of them have, at presentation, clinical stage I disease. This...
Post radical nephrectomy presenting with skull metastasis
10 April 2024
| Asif H Ansari, Tahseen Azim, Hamza Khan, Ramon Niekrash
|
URO - Urologic Oncology
We present the case of an 83-year-old female who underwent right radical nephrectomy for renal cell carcinoma (RCC). Despite negative surgical margins, the patient presented with a skull metastasis six years post radical nephrectomy. This case highlights the importance of...
